Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro

Kidney International

Volumn 58, Issue 5, 2000, Pages 1953-1962

  Yung, S ^a   Thomas, G J ^a   Davies, M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Extracellular matrix; HAS gene expression; Mesothelial cell migration; Peritoneal injury; Tissue repair; Wound repair

Indexed keywords

HYALURONIC ACID; TRITIUM; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; DIALYSIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY FAILURE; MESOTHELIUM CELL; NUCLEOTIDE SEQUENCE; PERITONEUM CELL; PERITONITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WOUND HEALING;

EID: 0033753655     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00367.x     Document Type: Article

References (45)

1. Hyaluronate is synthesised at plasma membranes
2. Hyaluronan synthases
3. Hyaluronan and its binding proteins, the hyaladherins
4. Hyaluronate receptors: Key players in growth, differentiation, migration and tumor progression
5. The ultrastructure of the parietal peritoneum in normal and uraemic man in patients on CAPD
6. Permanent loss of ultrafiltration capacity of the peritoneum in long term peritoneal dialysis: An epidemiological study
7. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity
8. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure
9. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis
10. Adherence of Staphylococci to plastic, mesothelial cells and mesothelial extracellular matrix
11. The mesothelial cells in CAPD effluent and their relation to peritonitis incidence
12. Hyaluronic acid: A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing
13. Treatment of tympanic membrane perforations with hyaluronan in an open pilot study of unselected patients
14. Repair of traumatically ruptured tympanic membrane using hyaluronan
15. Hyaluronan and healing of tympanic membrane perforations. An experimental study
16. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid
17. Clinical uses of hyaluronan
18. Hyaluronic acid (hyaluronan) in experimental osteoarthritis
19. The source and possible significance of hyaluronan in the peritoneal cavity
20. IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: Relevance to peritonitis in CAPD
21. Synthesis of hyaluronic acid by human peritoneal mesothelial cells: Effect of cytokines and dialysate
22. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD
23. Response of the human peritoneal mesothelial cell to injury: An in vitro model of peritoneal wound healing
24. Isolation, culture and characterization of human peritoneal mesothelial cells
25. The assay uridine diphosphoglucose dehydrogenase activity
26. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
27. Oxidation of low density lipoprotein by mesangial cells may promote gomerular damage
28. Mammalian hyaluronan synthases: Investigation of functional relationships in vivo
29. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties
30. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism
31. Hyaluronan fragments induce plasminogen activator inhibitor-1 and inhibit urokinase activity in mouse alveolar macrophages: A potential mechanism for impaired fibrinolytic activity in acute lung injury
32. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages
33. Angiogenesis induced by degradation products of hyaluronic acid
34. Immunomodulatory functions of hyaluronate in the LEW-to-F344 model of chronic cardiac allograft rejection
35. Molecular cloning of human hyaluronan synthase
36. Functional cloning of the cDNA for a human hyaluronan synthase
37. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family
38. Putative hyaluronan synthase mRNA are expressed in mouse skin and TGF-beta upregulates their expression in cultured human skin cells
39. Collagen production by human mesothelial cells in vitro
40. Source of peritoneal proteoglycans: Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans
41. Remodeling of peritoneal-like structures by mesothelial cells: Its role in peritoneal healing
42. Proteoglycans of the extracellular environment: Clues from the gene and protein side offer novel perspectives in molecular diversity and function
43. Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD
44. CD44 and its interaction with extracellular matrix
45. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity